Regent Pacific Group Limited (RPGLF)

Market Cap	29.81M +125.3%
Revenue (ttm)	363.00K -49.5%
Net Income	-4.71M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	175
Average Volume	14,441
Open	0.0059
Previous Close	n/a
Day's Range	0.0059 - 0.0059
52-Week Range	0.0007 - 0.4333
Beta	1.34
RSI	45.06
Earnings Date	Mar 26, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 17
• Stock Exchange: OTCMKTS
• Ticker Symbol: RPGLF

Financial Performance

In 2025, Regent Pacific Group's revenue was $363,000, a decrease of -49.51% compared to the previous year's $719,000. Losses were -$4.71 million, 5.09% more than in 2024.